FDA

FDA’s approval of an Ebola vaccine can serve as a framework for drug development during other epidemics.

As mobile medical applications continue to proliferate, regulators lack a solid framework for oversight.

A federal task force proposes regulatory solutions to mitigate drug shortages.

As people consume less meat and more meat alternatives, regulators have a role to play in ensuring accurate consumer information and safety.

A changing research environment means regulators and institutional review boards must adapt.

Lawyers and regulators are concerned about the lack of regulations for the use of robotic technology in surgeries.

FDA warns consumers that the agency has not evaluated most CBD products and cannot say they are safe.

Unlike new drugs and devices, combination products may fall through the regulatory cracks.

Congress should adopt stronger restrictions on former federal officials’ ability to lobby their old employers.

Scholar argues that FDA can, and should, regulate marijuana edibles.

FDA ought to promote stem cell therapy by easing up on regulation and its aggressive enforcement.

The Trump Administration plans to eliminate flavored vaping products from the market.